Notably, SMYD5 knockdown in a collagen-induced arthritis (CIA) mouse model improved synovial repair and alleviated joint injury, suggesting that SMYD5 may serve as a potential therapeutic target for RA. Here, SMYD5 is linked to rheumatoid arthritis.